Latest filing published 15 Jul 2026 for Nuvalent, Inc., €144k.
Insider track record
Christy J. Oliger: trading record in brief
Christy J. Oliger (board member) discloses dealings in 2 companies, chiefly Nuvalent, Inc. and Reata Pharmaceuticals Inc. In total, 6 filings cover trades dated from 8 June 2022 to 15 July 2026.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 15 July 2026 with a transaction (€144k) in Nuvalent, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Christy J. Oliger
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,324 shares@ US$124.000.0017% mcap100.0% of flowClass A Common StockSEC:0001193125-26-305081:0
- 6,091 sharesClass A Common Stock - Restricted Stock UnitsSEC:0001193125-26-305081:1
- 3,971 shares0Class A Common StockSEC:0000950170-25-088544:0
- 5,565 sharesClass A common stockSEC:0000899243-23-019544:0
- 1,682 shares@ US$93.6153.9% of flowClass A common stockSEC:0001209191-23-035850:0
- 3,883 shares@ US$34.7646.1% of flowClass A common stockSEC:0001209191-22-035418:0
6 of 6 declarations
